EAM
Exane Asset Management Portfolio holdings
AUM
$256M
This Quarter Return
+20%
1 Year Return
+8.08%
3 Year Return
+70.48%
5 Year Return
+81.39%
10 Year Return
–
AUM
$81.4M
AUM Growth
+$81.4M
(-38%)
Cap. Flow
-$56.9M
Cap. Flow
% of AUM
-69.86%
Top 10 Holdings %
Top 10 Hldgs %
76.08%
Holding
43
New
13
Increased
7
Reduced
7
Closed
15
Top Buys
| 1 |
Linde
LIN
|
$13.7M |
| 2 |
TIF
Tiffany & Co.
TIF
|
$5.35M |
| 3 |
CZR
Caesars Entertainment Corporation
CZR
|
$3.1M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
$2.31M |
| 5 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
$2.25M |
Top Sells
| 1 |
Alcon
ALC
|
$18.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
$11M |
| 3 |
CELG
Celgene Corp
CELG
|
$9.51M |
| 4 |
MDSO
Medidata Solutions, Inc.
MDSO
|
$9.35M |
| 5 |
Qiagen
QGEN
|
$9.24M |
Sector Composition
| 1 | Healthcare | 25.5% |
| 2 | Materials | 19.65% |
| 3 | Communication Services | 12.54% |
| 4 | Technology | 7.62% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Linde
LIN
$224B
| $14M | 17.15% |
65,190
+64,149
| +6,162% | +$13.7M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $11.2M | 13.71% |
58,402
+10,000
| +21% | +$1.91M |
|
|
ZAYO
3
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $10.2M | 12.52% |
294,221
+65,000
| +28% | +$2.25M |
|
4
AT&T
T
$209B
| $6.16M | 7.56% |
157,593
+34,548
| +28% | +$1.35M |
|
|
TIF
5
DELISTED
Tiffany & Co.
TIF
| $5.35M | 6.57% |
+40,000
| New | +$5.35M |
|
|
WAIR
6
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $3.99M | 4.91% |
362,431
+192,722
| +114% | +$2.12M |
|
|
CY
7
DELISTED
Cypress Semiconductor
CY
| $3.62M | 4.44% |
155,000
+30,000
| +24% | +$700K |
|
|
CZR
8
DELISTED
Caesars Entertainment Corporation
CZR
| $3.1M | 3.81% |
+228,200
| New | +$3.1M |
|
|
ATVI
9
DELISTED
Activision Blizzard Inc.
ATVI
| $2.31M | 2.83% |
+38,798
| New | +$2.31M |
|
|
INXN
10
DELISTED
Interxion Holding N.V.
INXN
| $2.1M | 2.57% |
+25,000
| New | +$2.1M |
|
|
11
Bristol-Myers Squibb
BMY
$96B
| $2.03M | 2.49% |
31,589
-171,268
| -84% | -$11M |
|
|
OMN
12
DELISTED
OMNOVA Solutions Inc.
OMN
| $1.96M | 2.41% |
193,761
-150,000
| -44% | -$1.52M |
|
13
Spotify
SPOT
$140B
| $1.95M | 2.4% |
+13,059
| New | +$1.95M |
|
|
WMGI
14
DELISTED
Wright Medical Group Inc
WMGI
| $1.83M | 2.25% |
+59,980
| New | +$1.83M |
|
|
FIT
15
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $1.44M | 1.77% |
+219,100
| New | +$1.44M |
|
|
MDCO
16
DELISTED
Medicines Co
MDCO
| $1.27M | 1.56% |
+15,000
| New | +$1.27M |
|
17
Ashland
ASH
$2.57B
| $1.15M | 1.41% |
15,000
-110,645
| -88% | -$8.47M |
|
18
Takeda Pharmaceutical
TAK
$47.3B
| $1.05M | 1.29% |
53,092
-9,546
| -15% | -$188K |
|
19
Pacific Biosciences
PACB
$393M
| $1.02M | 1.25% |
198,743
| – | – |
|
|
FTSV
20
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $932K | 1.14% |
23,674
-69,508
| -75% | -$2.74M |
|
|
KL
21
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $882K | 1.08% |
+20,000
| New | +$882K |
|
22
Amgen
AMGN
$155B
| $850K | 1.04% |
3,526
-20,482
| -85% | -$4.94M |
|
|
DPLO
23
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $800K | 0.98% |
+200,000
| New | +$800K |
|
24
CytomX Therapeutics
CTMX
$336M
| $730K | 0.9% |
87,876
+33,811
| +63% | +$281K |
|
25
uniQure
QURE
$896M
| $717K | 0.88% |
+10,000
| New | +$717K |
|